The National Pharmaceutical Pricing Authority (NPPA), on August 13, 2026, under the Drugs (Prices Control) Order, 2013 (DPCO, 2013), has computed the retail price for the formulation containing Cholecalciferol, Pyridoxine HCl, Niacinamide, Cyanocobalamin, Selenium, Zinc, Manganese, Molybdenum, L-Lysine, Iodine, Biotin, Chromium, Myo-inositol and Beta Carotene, manufactured by M/s Ordain Healthcare Global Pvt. Ltd. and marketed by M/s Mapra Laboratories Pvt. Ltd.
Based on December 2025 market data under Para 5 of the DPCO, 2013, the worked-out and proposed retail price is ₹3.20 per ml, excluding GST. The price calculation considers the market data of companies having a market share of 1% and above and includes the prescribed 16% retailer margin.
The formulation is available in the market through products including TIS Healthcare Ltd., AxBex Ozone Pharmaceuticals and Bevon (Zuventus Healthcare Ltd.). The proposed retail price of ₹3.20 per ml is therefore determined based on the applicable market-based pricing methodology under DPCO, 2013.
[File No. 19(5276)/2026/DP/NPPA/Div.II]
